Latest Infections: Misc. news
September 2018 Briefing – Infectious Disease
by modernClinician Editorial Team
Here are what the editors at HealthDay consider to be the most important developments in Infectious Disease for September 2018. This roundup includes the latest research news from journal articles, […]
FDA Approves New Drug for Antibiotic-Resistant Lung Disease
by modernClinician Editorial Team
Arikayce (amikacin liposome inhalation suspension) has been approved by the U.S. Food and Drug Administration to treat lung disease caused by Mycobacterium avium complex bacteria among patients who do not respond to conventional therapies, the FDA said in a news release.
Critics Demand Stop to ‘Guinea Pig’ Sepsis Clinical Trial
by modernClinician Editorial Team
A major non-profit advocacy group is asking that a large government trial comparing treatments for sepsis be shut down.
Patrons of ‘Vampire Facial’ Spa May Have Been Exposed to HIV
by modernClinician Editorial Team
Customers of an Albuquerque spa who received a "vampire facial" are being warned that they may have been exposed to HIV, hepatitis B and hepatitis C through human blood used in the controversial procedure.
Considerable Global Disparities Found in Access to Dermatological Care 
Collagen Supplements Beneficial for Dermal, Bone, Musculoskeletal Health 
Hyaluronic Acid Fillers Restore Facial Volume, Fullness 
Lebrikizumab Efficacious, Safe for Patients With Skin of Color, Eczema Related Articles
Few Staff Receive Formal Training on CLABSI Surveillance for Home Infusion 
7.7 Million Deaths Associated With 33 Bacterial Pathogens in 2019 
U.S. Deaths From Infective Endocarditis Increasing in the Young 
Antiseptics Work Equally Well in Preventing Infection After Surgery for Open Fractures Monthly Specialist Briefings
Stay Connected
